HBsAg rapid test complete guide infographic explaining hepatitis B surface antigen Reactive Non-Reactive results anti-HBs anti-HBc and HBV DNA differences

HBsAg Rapid Test Kit Complete Guide: Hepatitis B Screening, Results & What HBsAg Detects

An HBsAg rapid test is used to screen for hepatitis B surface antigen, an important marker associated with current hepatitis B virus (HBV) infection.

HBsAg testing is widely used in hepatitis B screening, including in laboratories, healthcare facilities, blood-screening programmes and antenatal care.

But an HBsAg result must be interpreted correctly.

HBsAg is an antigen—not a hepatitis B antibody.

A Reactive HBsAg result indicates that hepatitis B surface antigen has been detected, but an HBsAg rapid test alone does not tell you whether the infection is acute or chronic, how much virus is present, how much liver damage exists or whether treatment is required.

This guide explains what HBsAg means, how HBsAg rapid tests work, what Reactive and Non-Reactive results mean, how HBsAg differs from anti-HBs and anti-HBc, and what additional assessment may be required after a Reactive screening result.

What Is Hepatitis B?

Hepatitis B is a viral infection caused by the hepatitis B virus (HBV).

HBV primarily affects the liver.

Hepatitis B infection can be:

  • Acute, meaning relatively recent infection
  • Chronic, meaning infection persists over time

Chronic hepatitis B can increase the risk of serious liver disease, including cirrhosis and hepatocellular carcinoma.

However, determining whether someone has acute infection, chronic infection, inactive infection or clinically significant liver disease requires more information than a single HBsAg rapid test.

What Does HBsAg Mean?

HBsAg stands for:

Hepatitis B Surface Antigen

It is a protein associated with the surface of hepatitis B virus particles.

Detection of HBsAg in blood generally indicates current hepatitis B virus infection, which may be acute or chronic. WHO recognizes HBsAg testing using either rapid diagnostic tests or laboratory immunoassays as an important approach to screening and identifying HBV infection.

Is HBsAg an Antibody?

No.

This is one of the most important distinctions in hepatitis B testing.

HBsAg is an antigen.

It should not be confused with hepatitis B antibody markers such as:

  • Anti-HBs — antibody to hepatitis B surface antigen
  • Anti-HBc — antibody to hepatitis B core antigen
  • IgM anti-HBc — an important marker used when evaluating recent/acute hepatitis B infection

These markers answer different clinical questions.

HBsAg vs Anti-HBs: What Is the Difference?

Marker What It Is General Significance
HBsAg Hepatitis B surface antigen Indicates current HBV infection when detected, subject to appropriate evaluation
Anti-HBs Antibody against hepatitis B surface antigen May indicate immunity following vaccination or recovery from infection, depending on the complete serological pattern

Therefore:

HBsAg Reactive does not mean “hepatitis B antibodies are positive.”

And:

Anti-HBs positive does not mean the same thing as HBsAg Reactive.

HBsAg vs Anti-HBc: What Is the Difference?

Anti-HBc is antibody directed against the hepatitis B core antigen.

Anti-HBc can provide useful information about previous or current natural exposure to HBV and is interpreted together with other hepatitis B markers.

Importantly, hepatitis B vaccination alone generally produces anti-HBs rather than anti-HBc.

HBsAg, anti-HBs and anti-HBc should therefore not be treated as interchangeable names for a “hepatitis B test.”

What Is an HBsAg Rapid Test?

An HBsAg rapid diagnostic test is an in vitro diagnostic assay designed to detect hepatitis B surface antigen.

Many HBsAg RDTs use immunochromatographic lateral-flow technology.

In simplified terms:

  1. A permitted specimen is applied to the test.
  2. The specimen moves through the test membrane.
  3. If HBsAg is present at a detectable level, it interacts with assay reagents.
  4. A visual test reaction develops according to the product's design.
  5. A control indicator helps establish whether the test has functioned correctly.

The exact specimen volume, buffer quantity, testing time and result interpretation must come from the Instructions for Use supplied with the specific product.

What Does an HBsAg Rapid Test Detect?

An HBsAg test detects:

Hepatitis B surface antigen.

It does not directly measure:

  • Hepatitis B viral load
  • HBV DNA quantity
  • Anti-HBs immunity
  • Anti-HBc
  • Liver fibrosis
  • Liver enzyme levels
  • Severity of liver disease

An HBsAg rapid test therefore answers an important but specific question.

What Specimens Can Be Used for HBsAg Rapid Testing?

The permitted specimen depends on the exact product.

HBsAg assays may be designed for specimens such as:

  • Capillary whole blood
  • Venous whole blood
  • Serum
  • Plasma

WHO lists HBsAg RDTs using capillary or venous whole blood among hepatitis B diagnostic tools used in appropriate settings.

However, a specimen permitted for one HBsAg test must not automatically be assumed to be suitable for another.

Microsidd HBsAg Fast Test Kit Mono Pack

The Microsidd HBsAg Fast Test Kit Mono Pack is currently listed as a single-use rapid screening product for detecting HBsAg.

The current Microsidd product information identifies:

Feature Current Product Information
Target Hepatitis B surface antigen (HBsAg)
Test type Rapid immunochromatographic screening test
Specimen Fingerstick whole blood
Format 1 Test Mono Pack
Use Single use
Current listed result time Approximately 10–15 minutes

The current product page describes the kit as an initial screening aid rather than a standalone diagnostic assessment.

The detailed testing procedure will be covered separately in:

How to Use an HBsAg Rapid Test Kit

For that article, specimen volume, buffer quantity, exact timing and result interpretation will be checked against the applicable manufacturer instructions rather than assumed from another HBsAg assay.

What Does a Reactive HBsAg Result Mean?

A Reactive HBsAg result means hepatitis B surface antigen was detected by the assay.

This is evidence that requires appropriate hepatitis B evaluation.

However, an HBsAg Reactive result by itself does not answer all of the following questions:

  • Is the infection acute or chronic?
  • When was the infection acquired?
  • What is the HBV viral load?
  • How actively is the virus replicating?
  • Is there liver inflammation?
  • Is there liver fibrosis or cirrhosis?
  • Does the individual currently require antiviral treatment?

Those questions require appropriate additional laboratory and clinical assessment.

Does HBsAg Reactive Mean Hepatitis B Is Definitely Chronic?

No.

HBsAg may be detected during either acute or chronic HBV infection.

Persistence of HBsAg over time is important in identifying chronic hepatitis B. Chronic HBV infection is classically defined by persistence of HBsAg for at least six months.

A single HBsAg result therefore cannot by itself establish how long the infection has been present.

How Is Acute Hepatitis B Distinguished from Chronic Hepatitis B?

Additional hepatitis B markers and clinical information are needed.

For example, IgM antibody to hepatitis B core antigen (IgM anti-HBc) is an important marker used together with HBsAg when evaluating acute HBV infection. WHO's diagnostic framework specifically notes the role of IgM anti-HBc in evaluating acute hepatitis B.

Other information may include:

  • Previous HBsAg results
  • Duration of HBsAg detection
  • Clinical symptoms
  • Liver enzymes
  • HBV DNA
  • Other HBV serological markers

What Does a Non-Reactive HBsAg Result Mean?

A Non-Reactive result means HBsAg was not detected by the particular assay under the conditions in which the test was performed.

This may be reassuring, but it should not automatically be interpreted as:

“This person has never been exposed to hepatitis B.”

HBsAg testing alone does not provide a complete hepatitis B serological history.

For example, assessing immunity or previous exposure may require other markers such as anti-HBs and anti-HBc.

Does Non-Reactive HBsAg Mean Someone Is Immune to Hepatitis B?

No.

A Non-Reactive HBsAg result tells you that hepatitis B surface antigen was not detected.

It does not tell you whether protective anti-HBs antibodies are present.

To assess immunity, an appropriate anti-HBs test and, depending on the clinical question, other hepatitis B markers may be needed.

Does HBsAg Testing Show Whether Someone Has Been Vaccinated?

Not by itself.

HBsAg testing detects surface antigen associated with current infection.

Assessment of hepatitis B immunity after vaccination generally involves anti-HBs, not HBsAg.

This is another reason the terms should never be confused.

What Is an Invalid HBsAg Rapid Test?

An Invalid rapid-test result means the device did not satisfy the manufacturer's validity criteria.

For example, if a required control indicator does not appear, the test cannot reliably be interpreted.

An Invalid test is:

Not Reactive.

Not Non-Reactive.

It provides no usable screening conclusion.

The manufacturer's instructions should be followed regarding repeat testing with a new device.

Reactive, Non-Reactive and Invalid: Quick Reference

Result General Meaning Next Consideration
Reactive HBsAg detected by the screening assay Appropriate laboratory and clinical hepatitis B evaluation
Non-Reactive HBsAg not detected Interpret according to clinical context; this does not establish immunity
Invalid Test validity requirements not met Repeat according to the exact IFU

What Tests May Be Needed After Reactive HBsAg?

The appropriate evaluation varies according to the healthcare setting and individual circumstances.

It can include tests such as:

  • Laboratory HBsAg testing where appropriate
  • HBV DNA
  • HBeAg
  • Anti-HBe
  • Anti-HBc
  • IgM anti-HBc when acute infection is being considered
  • Alanine aminotransferase (ALT)
  • Aspartate aminotransferase (AST)
  • Other assessment of liver disease where clinically indicated

WHO's current HBV guidance particularly emphasizes the role of HBV DNA in staging infection, determining treatment eligibility in appropriate patients and monitoring treatment.

What Is HBV DNA?

HBV DNA testing detects and can quantify hepatitis B viral genetic material in the blood.

It provides different information from an HBsAg rapid test.

HBsAg test:
Detects hepatitis B surface antigen.

HBV DNA test:
Detects hepatitis B viral DNA and can be used to assess viral replication and guide clinical management.

Therefore:

HBsAg test ≠ HBV viral-load test.

Does a Darker HBsAg Test Line Mean a Higher HBV Viral Load?

No.

A qualitative HBsAg rapid test is not an HBV DNA quantification test.

Line intensity should not be used to estimate:

  • HBV DNA level
  • Severity of infection
  • Degree of liver injury
  • Risk of cirrhosis
  • Need for treatment

A viral-load measurement requires an appropriate HBV DNA assay.

What Is HBeAg?

HBeAg means hepatitis B e antigen.

It is a different hepatitis B marker from HBsAg.

HBeAg can provide information related to viral replication and is used in particular clinical and public-health contexts.

However, HBeAg and HBsAg should not be confused:

HBsAg → hepatitis B surface antigen

HBeAg → hepatitis B e antigen

HBsAg vs HBeAg

HBsAg HBeAg
Surface antigen e antigen
Used to identify current HBV infection Can provide additional information related to HBV replication
Common first-line hepatitis B screening marker Used in additional clinical assessment in selected situations

Can HBsAg Testing Diagnose Liver Damage?

No.

An HBsAg result does not tell you how much liver damage has occurred.

Assessment of hepatitis B-related liver disease may involve:

  • Liver enzymes
  • Platelet count
  • Non-invasive fibrosis assessment
  • Ultrasound or other imaging where appropriate
  • HBV DNA
  • Other clinical assessment

WHO's updated chronic hepatitis B guidance includes simplified approaches for assessing liver disease and treatment eligibility.

Does Everyone with Reactive HBsAg Need Hepatitis B Treatment?

No.

Detection of HBsAg identifies a person who requires appropriate evaluation, but treatment decisions depend on additional clinical factors.

These may include:

  • HBV DNA level
  • Presence or absence of liver fibrosis or cirrhosis
  • ALT and other laboratory findings
  • Age and clinical history
  • Pregnancy in relevant circumstances
  • Other medical conditions

WHO updated and simplified hepatitis B treatment eligibility criteria in its 2024 guidelines.

How Is Hepatitis B Transmitted?

HBV can be transmitted through infected blood and certain body fluids.

Important routes include:

  • Mother-to-child transmission around birth
  • Unsafe injections or contaminated needles
  • Exposure to infected blood
  • Sexual transmission
  • Sharing contaminated sharp instruments

HBV is also vaccine-preventable.

Is Hepatitis B the Same as Hepatitis C?

No.

Hepatitis B and hepatitis C are caused by different viruses and use different screening markers.

Hepatitis B Hepatitis C
Caused by HBV Caused by HCV
Common initial marker: HBsAg Common initial marker: anti-HCV antibodies
Effective vaccination is available No preventive HCV vaccine is currently available
HBV DNA is relevant to further assessment HCV RNA is used to establish current HCV infection after antibody screening

A Reactive HBsAg result says nothing about HCV status, and a Reactive HCV antibody result says nothing about HBsAg status.

Is Hepatitis B the Same as HIV?

No.

HIV and HBV are different viruses.

An HIV antibody rapid test screens for HIV-related antibodies or other HIV markers depending on the assay.

An HBsAg test detects hepatitis B surface antigen.

One cannot be used to determine the result of the other.

HBsAg Screening During Pregnancy

HBsAg screening has particular importance during pregnancy because hepatitis B can be transmitted from mother to child around the time of birth.

India's National Viral Hepatitis Control Programme specifically promotes HBsAg screening in pregnancy and referral of HBsAg-positive pregnant women into an appropriate care pathway.

WHO's current hepatitis B guidance also includes interventions to prevent mother-to-child transmission, including assessment of eligible HBsAg-positive pregnant women for antiviral prophylaxis based on appropriate further testing.

We will cover this in depth in:

Hepatitis B / HBsAg Screening During Pregnancy

Why Is Early Identification During Pregnancy Important?

Identifying maternal HBV infection before delivery gives healthcare professionals time to:

  • Evaluate maternal hepatitis B infection
  • Assess HBV DNA or other markers where indicated
  • Determine whether maternal antiviral prophylaxis is appropriate
  • Plan delivery and newborn preventive care
  • Ensure timely hepatitis B vaccination of the newborn

WHO and Indian guidance both emphasize prevention of mother-to-child transmission as a major component of hepatitis B control.

Does Reactive HBsAg Mean Caesarean Delivery Is Required?

No.

Indian viral hepatitis guidance states that hepatitis B infection itself is not a reason to choose caesarean delivery; mode of delivery should be based on obstetric indications.

What Happens to a Baby Born to a Mother with Hepatitis B?

Newborn preventive care is extremely important.

India's NVHCP emphasizes timely hepatitis B birth-dose vaccination, and specific programmes may also use hepatitis B immunoglobulin (HBIG) for infants born to HBsAg-positive mothers according to applicable guidance and availability.

The exact maternal and newborn pathway should be managed by the antenatal and neonatal healthcare team.

HBsAg Is Part of the WHO Triple-Elimination Framework

WHO's Triple Elimination initiative addresses mother-to-child transmission of:

  • HIV
  • Syphilis
  • Hepatitis B

HBsAg screening is therefore closely connected with the maternal infection pathway already developed in the Microsidd Knowledge Hub.

Read:

Who May Need Hepatitis B Testing?

HBV testing can be relevant in a range of clinical and public-health contexts, including antenatal screening and evaluation of people with potential HBV exposure or risk factors.

The decision about which hepatitis B markers to test should be based on the clinical question and applicable healthcare guidance.

HBsAg alone should not be viewed as a universal replacement for a complete hepatitis B serological assessment.

Can an HBsAg Rapid Test Be Used at Home?

This depends on the intended use of the exact product.

The current Microsidd HBsAg Fast Test Kit Mono Pack is listed as a fingerstick whole-blood home-screening product.

However, even when a product is designed for home screening:

Reactive → seek appropriate laboratory and medical evaluation.

Unexpected Non-Reactive result → seek medical evaluation if clinically indicated.

A home screening test should not replace professional hepatitis B assessment where symptoms, pregnancy, known exposure or other medical indications exist.

Can an HBsAg Rapid Test Be Reused?

No.

The current Microsidd HBsAg Mono Pack is a single-use test.

Once specimen and buffer have migrated through the test device, the cassette cannot be reset or reused reliably.

What Can Affect HBsAg Rapid-Test Reliability?

Important factors can include:

  • Using the wrong specimen
  • Incorrect specimen volume
  • Incorrect buffer quantity
  • Using the wrong buffer
  • Reading the result too early
  • Reading the result too late
  • Using an expired test
  • Improper storage
  • Using a damaged test pouch
  • Ignoring an invalid control

These practical issues will be covered separately in:

HBsAg Rapid Test Do's, Don'ts & Common Errors

Upcoming Microsidd HBsAg Knowledge Hub Guides

Frequently Asked Questions

What is HBsAg?

HBsAg stands for hepatitis B surface antigen. Detection of HBsAg indicates current hepatitis B virus infection and requires appropriate interpretation and follow-up.

Is HBsAg an antibody?

No. HBsAg is an antigen. Anti-HBs is the antibody directed against hepatitis B surface antigen.

What does an HBsAg rapid test detect?

It detects hepatitis B surface antigen.

What does a Reactive HBsAg test mean?

It means HBsAg was detected by the screening assay. Appropriate medical and laboratory evaluation is needed to determine the nature and clinical significance of the infection.

Does Reactive HBsAg mean chronic hepatitis B?

Not necessarily. HBsAg may occur in acute or chronic infection. Persistence of HBsAg for at least six months is an important criterion used to define chronic HBV infection.

Does a Non-Reactive HBsAg result mean I am immune to hepatitis B?

No. HBsAg and anti-HBs provide different information. Immunity assessment generally involves anti-HBs and may require interpretation with other hepatitis B markers.

Does HBsAg testing measure viral load?

No. HBV viral load is measured using HBV DNA testing.

Does a darker HBsAg rapid-test line mean more virus?

No. A qualitative rapid test should not be used to estimate HBV DNA level or severity of infection.

What is the difference between HBsAg and HBeAg?

HBsAg is hepatitis B surface antigen and is commonly used to identify current HBV infection. HBeAg is a different viral marker that can provide additional information related to viral replication.

What is the difference between HBsAg and anti-HBs?

HBsAg is a viral surface antigen associated with current infection. Anti-HBs is an antibody that can indicate immunity after vaccination or recovery, depending on the complete serological pattern.

Can HBsAg tell whether hepatitis B is acute or chronic?

Not from one result alone. Additional testing and the duration of HBsAg persistence are important. IgM anti-HBc is particularly relevant when acute hepatitis B is being evaluated.

Does everyone with Reactive HBsAg need treatment?

No. Treatment decisions require further assessment, including factors such as liver disease, HBV DNA and other clinical information.

Is HBsAg screening important during pregnancy?

Yes. Identifying HBV infection during pregnancy allows appropriate maternal evaluation and planning of measures intended to reduce mother-to-child transmission.

Is hepatitis B vaccine available?

Yes. Hepatitis B is vaccine-preventable, and timely birth-dose vaccination is an important component of preventing mother-to-child HBV transmission.

Is HBsAg the same as HCV antibody testing?

No. HBsAg screens for hepatitis B surface antigen, while anti-HCV testing screens for antibodies associated with hepatitis C virus exposure.

Can the Microsidd HBsAg Fast Test Kit be reused?

No. The current product is intended for single use.

What specimen does the current Microsidd HBsAg Mono Pack use?

The current Microsidd product listing specifies fingerstick whole blood. Follow the instructions supplied with the exact kit for specimen collection and application.

Continue Through the Microsidd HBsAg / Hepatitis B Hub

Return to the Maternal & Infectious Disease Screening Hub

Microsidd HBsAg Fast Test Kit Mono Pack

View the current HBsAg screening product:

Microsidd HBsAg Fast Test Kit Mono Pack – 1 Test

The current product is listed as a single-use fingerstick whole-blood rapid screening test for hepatitis B surface antigen.

Always follow the instructions supplied with the exact kit and seek appropriate healthcare evaluation following a Reactive or unexpected result.

Medical Information Notice

This article is intended for general educational and product-information purposes and does not replace medical consultation, laboratory diagnosis, clinical hepatitis B assessment or the manufacturer's Instructions for Use.

An HBsAg rapid test detects hepatitis B surface antigen but does not by itself determine whether HBV infection is acute or chronic, quantify HBV DNA, assess liver damage or determine whether antiviral treatment is required.

A Reactive HBsAg screening result should receive appropriate laboratory and clinical evaluation. A Non-Reactive result does not establish immunity to hepatitis B and may not answer every hepatitis B testing question.

Pregnant women with Reactive HBsAg should receive appropriate antenatal and hepatitis B evaluation so that maternal care and measures to reduce mother-to-child transmission can be planned according to current clinical guidance.

Previous Next

Leave a comment

0 comments

Please note, comments need to be approved before they are published.